{
  "metadata": {
    "Designs": ["Randomized Controlled Trial"],
    "Types": [],
    "BriefSummary": "To determine the efficacy, long-term safety, and tolerability of alirocumab 300 mg every 4\n weeks (Q4W), in comparison with placebo, as well as its potential as a starting regimen. The\n dose regimen of 75 mg every 2 weeks (Q2W), as used in other studies, was added as a\n calibrator.",
    "Abstract": "To determine the efficacy, long-term safety, and tolerability of alirocumab 300 mg every 4\n weeks (Q4W), in comparison with placebo, as well as its potential as a starting regimen. The\n dose regimen of 75 mg every 2 weeks (Q2W), as used in other studies, was added as a\n calibrator.",
    "Acronym": null,
    "ArticleId": "Qy3gwKWSoaWRmbmFEQA",
    "Authors": null,
    "CochraneID": null,
    "Confidential": false,
    "CorporateAuthor": null,
    "Country": "Bulgaria, Canada, Hungary, Israel, Norway, Slovakia, United Kingdom, United States",
    "CustomData": null,
    "DatabaseType": "ClinicalTrials.gov",
    "DOI": null,
    "EmbaseAccessionNumber": null,
    "Emtree": null,
    "ErrataText": null,
    "FullTextURL": null,
    "Institution": null,
    "ISSN": null,
    "Issue": null,
    "JournalTitle": null,
    "MedlineID": null,
    "MeSH": "Hypercholesterolemia|Antibodies, Monoclonal",
    "Pages": null,
    "ParentChildStatus": null,
    "ParentID": null,
    "PublicationDate": "March 21, 2017",
    "PublicationYear": 2017,
    "PubType": null,
    "ReferenceStudy": null,
    "SecondarySourceID": null,
    "Source": "Regeneron Pharmaceuticals",
    "SourceReferenceId": "NCT01926782",
    "TaStudyDesign": "Randomized",
    "Title": "A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of an Every Four Weeks Treatment Regimen of Alirocumab in Patients With Primary Hypercholesterolemia",
    "TrialOutcome": null,
    "Volume": null,
    "Id": 179246831,
    "Created": "2020-04-10T14:48:20.4384957Z",
    "VersionNo": 2,
    "ExtractData": null,
    "Digitized": true,
    "IsRapidExtract": false,
    "IsUploaded": false
  },
  "design": "Randomized Controlled Trial",
  "conditions": [{ "label": "Cholesterol Total Increased", "id": "SUE_c" }],
  "phase": 3,
  "name": "NCT01926782",
  "trialIds": ["NCT01926782"],
  "acronyms": [],
  "outcomeCount": 156,
  "id": 179246831,
  "groups": [
    {
      "Id": "4r",
      "RefId": "B5|O2~Alirocumab 75 mg Q2W/Up 150 mg Q2W Without Concomitant Statin",
      "OriginalName": "Alirocumab 75 mg Q2W/Up 150 mg Q2W Without Concomitant Statin",
      "N": 37,
      "age": 59.3,
      "ageSD": 11.3,
      "male": 37.83783783783784,
      "Interventions": [{ "termIds": [["SUBYEL", "SUB_Oc"], ["SUNUVb"]] }],
      "analyzeAs": "Alirocumab",
      "analyzableScore": 1.0717734625362931,
      "matchingScore": 0
    },
    {
      "Id": "zB",
      "RefId": "B6|O3~Alirocumab 300 mg Q4W/Up 150 mg Q2W Without Concomitant Statin",
      "OriginalName": "Alirocumab 300 mg Q4W/Up 150 mg Q2W Without Concomitant Statin",
      "N": 146,
      "age": 59.2,
      "ageSD": 10.8,
      "male": 45.205479452054796,
      "Interventions": [{ "termIds": [["SUBYEL", "SUB_Oc"]] }],
      "analyzeAs": "Statins",
      "analyzableScore": 1.0717734625362931,
      "matchingScore": 0
    },
    {
      "Id": "3!",
      "RefId": "B4|O1~Placebo Q2W Without Concomitant Statin",
      "OriginalName": "Placebo Q2W Without Concomitant Statin",
      "N": 73,
      "age": 59.4,
      "ageSD": 10.2,
      "male": 54.794520547945204,
      "Interventions": [{ "termIds": [["SUGeLS"], ["SUBYEL", "SUB_Oc"]] }],
      "analyzeAs": "Control",
      "analyzableScore": 1.2020833333333334,
      "matchingScore": 0
    },
    {
      "Id": "tv",
      "RefId": "E3",
      "OriginalName": "Alirocumab 300 mg Q4W/Up 150 mg Q2W",
      "Interventions": [{ "termIds": [["SUCO54", "SUNUVb"]] }]
    },
    {
      "Id": "jt",
      "RefId": "B3|O3~Alirocumab 300 mg Q4W/Up 150 mg Q2W With Concomitant Statin",
      "OriginalName": "Alirocumab 300 mg Q4W/Up 150 mg Q2W With Concomitant Statin",
      "N": 312,
      "age": 61.6,
      "ageSD": 10,
      "male": 60.8974358974359,
      "Interventions": [{ "termIds": [["SUBYEL", "SUB_Oc"]] }]
    },
    {
      "Id": "5!",
      "RefId": "E2",
      "OriginalName": "Alirocumab 75 mg Q2W/Up 150 mg Q2W",
      "Interventions": [{ "termIds": [["SUNUVb"]] }]
    },
    {
      "Id": "4E",
      "RefId": "B2|O2~Alirocumab 75 mg Q2W/Up 150 mg Q2W With Concomitant Statin",
      "OriginalName": "Alirocumab 75 mg Q2W/Up 150 mg Q2W With Concomitant Statin",
      "N": 78,
      "age": 60.7,
      "ageSD": 9.1,
      "male": 65.38461538461539,
      "Interventions": [{ "termIds": [["SUBYEL", "SUB_Oc"], ["SUNUVb"]] }]
    },
    {
      "Id": "i4",
      "Interventions": [
        {
          "Id": "Ya",
          "Name": 178613599,
          "Treatments": [{ "Id": "((", "Phase": "k)" }],
          "Type": "Drug",
          "termIds": [["SUGeLS"], ["SUNUVb"]],
          "terms": [["Placebo"], ["Alirocumab"]]
        },
        {
          "Id": "o)",
          "Name": 2159990,
          "Treatments": [{ "Id": "1$", "Phase": "k)" }],
          "Type": "Drug",
          "termIds": [["SUBYEL"]],
          "terms": [["Statins"]]
        }
      ],
      "RefId": "E1|Placebo Q2W",
      "OriginalName": "Placebo Q2W"
    },
    {
      "Id": "Ls",
      "RefId": "B1|O1~Placebo Q2W With Concomitant Statin",
      "OriginalName": "Placebo Q2W With Concomitant Statin",
      "N": 157,
      "age": 61.6,
      "ageSD": 9.7,
      "male": 64.3312101910828,
      "Interventions": [{ "termIds": [["SUGeLS"], ["SUBYEL", "SUB_Oc"]] }]
    }
  ],
  "hasDocData": true,
  "hasRapidExtract": false,
  "N": 803,
  "queryScore": 1.4868329805051381,
  "matchingScore": 7.960635921410255,
  "score": 22.084654254966498,
  "outcomes": [
    {
      "id": "179246387",
      "type": "Change",
      "unit": "%",
      "termIds": [["SUF0R", "SUBskP"]],
      "quantifiers": [],
      "name": "Calculated LDL-C in Not Receiving Concomitant Statin Therapy - On-Treatment Analysis",
      "cells": [
        {
          "number": -0.4,
          "unit": "%",
          "group": "3!",
          "varType": "se",
          "N": 70,
          "se": 2,
          "sd": 16.73
        },
        {
          "number": -54.6,
          "unit": "%",
          "group": "4r",
          "varType": "se",
          "N": 37,
          "se": 2.8,
          "sd": 17.03
        },
        {
          "number": -59.4,
          "unit": "%",
          "group": "zB",
          "varType": "se",
          "N": 141,
          "se": 1.4,
          "sd": 16.62
        }
      ],
      "time": {
        "Id": 67122072,
        "Low": { "Value": "Baseline" },
        "High": { "Number": 24, "Unit": "wk" },
        "Type": "Total",
        "days": 168,
        "description": "24wk"
      },
      "score": 2.08,
      "matchingTerm": "SUF0R",
      "suggestedPositive": false,
      "sourceUnit": "%"
    },
    {
      "id": "179246389",
      "type": "Change",
      "unit": "%",
      "termIds": [["SUF0R", "SUBskP"]],
      "quantifiers": [],
      "name": "Calculated LDL-C in Receiving Concomitant Statin Therapy - On-Treatment Analysis",
      "cells": [
        {
          "number": -0.3,
          "unit": "%",
          "group": "Ls",
          "varType": "se",
          "N": 151,
          "se": 2.1,
          "sd": 25.81
        },
        {
          "number": -55.1,
          "unit": "%",
          "group": "4E",
          "varType": "se",
          "N": 75,
          "se": 3,
          "sd": 25.98
        },
        {
          "number": -62.3,
          "unit": "%",
          "group": "jt",
          "varType": "se",
          "N": 302,
          "se": 1.5,
          "sd": 26.07
        }
      ],
      "time": {
        "Id": 67122072,
        "Low": { "Value": "Baseline" },
        "High": { "Number": 24, "Unit": "wk" },
        "Type": "Total",
        "days": 168,
        "description": "24wk"
      },
      "score": 2.08,
      "matchingTerm": "SUF0R",
      "suggestedPositive": false,
      "sourceUnit": "%"
    },
    {
      "id": "179246393",
      "type": "Change",
      "unit": "%",
      "termIds": [["SUF0R", "SUBskP"]],
      "quantifiers": [],
      "name": "Calculated LDL-C in Not Receiving Concomitant Statin Therapy - On-Treatment Analysis",
      "cells": [
        {
          "number": -0.5,
          "unit": "%",
          "group": "3!",
          "varType": "se",
          "N": 70,
          "se": 2,
          "sd": 16.73
        },
        {
          "number": -53.9,
          "unit": "%",
          "group": "4r",
          "varType": "se",
          "N": 37,
          "se": 2.7,
          "sd": 16.42
        },
        {
          "number": -60,
          "unit": "%",
          "group": "zB",
          "varType": "se",
          "N": 141,
          "se": 1.4,
          "sd": 16.62
        }
      ],
      "time": {
        "Id": 67122069,
        "Low": { "Value": "Baseline" },
        "High": { "Number": 12, "Unit": "wk" },
        "Type": "Total",
        "days": 84,
        "description": "12wk"
      },
      "score": 2.08,
      "matchingTerm": "SUF0R",
      "suggestedPositive": false,
      "sourceUnit": "%"
    },
    {
      "id": "179246394",
      "type": "Change",
      "unit": "%",
      "termIds": [["SUF0R", "SUBskP"]],
      "quantifiers": [],
      "name": "Calculated LDL-C in Receiving Concomitant Statin Therapy - On-Treatment Analysis",
      "cells": [
        {
          "number": 1.4,
          "unit": "%",
          "group": "Ls",
          "varType": "se",
          "N": 151,
          "se": 1.9,
          "sd": 23.35
        },
        {
          "number": -47.3,
          "unit": "%",
          "group": "4E",
          "varType": "se",
          "N": 75,
          "se": 2.8,
          "sd": 24.25
        },
        {
          "number": -58,
          "unit": "%",
          "group": "jt",
          "varType": "se",
          "N": 302,
          "se": 1.4,
          "sd": 24.33
        }
      ],
      "time": {
        "Id": 67122069,
        "Low": { "Value": "Baseline" },
        "High": { "Number": 12, "Unit": "wk" },
        "Type": "Total",
        "days": 84,
        "description": "12wk"
      },
      "score": 2.08,
      "matchingTerm": "SUF0R",
      "suggestedPositive": false,
      "sourceUnit": "%"
    }
  ],
  "characteristics": [
    {
      "id": "179246354",
      "type": "Binary",
      "isCharacteristic": true,
      "termIds": [["SUE_c", "SUCbN", "SUyJj"]],
      "quantifiers": [],
      "name": "Patients not having adequate control of their hypercholesterolemia based on their individual level of CVD risk",
      "cells": [],
      "number": 100
    }
  ],
  "outcomesScore": 18.97947630112307
}
